CSIMarket Company Name, Ticker, Customers, else..
 
Idexx Laboratories Inc  (IDXX)
Other Ticker:  
 
 

Idexx Laboratories Inc Growth Comparisons

Select each growth Category to receive further Information



IDXX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 8.76 % 14.93 % - -
Q / Q Revenue Growth (Q4 MRQ) -1.51 % 2.36 % - -
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 8.69 % 14.66 % - %
Seq. Revenue Growth (for 12 months ending Q4 TTM) 2.02 % 3.43 % - 0.27 %
Revenue 5 Year Average Growth 10.58 % 11.86 % 7.59 % 8.14 %


IDXX's Growth Comparisons in IV. Quarter 2023




Comparing 8.76% year on year top-line growth in the forth quarter 2023, Idexx Laboratories Inc grew on the lower pace than the 14.93% rise in the In Vitro & In Vivo Diagnostic Substances industry, but beating the % no change in the Healthcare sector.

Top-line fell by -1.51% from the third quarter. Average annual sales growth for Idexx Laboratories Inc is 10.58%, while S & P 500's average yearly sales increase is 8.14%, including only Businesses with the forth quarter 2023 financial results.


Growth Rates of IDXX's Income in the forth quarter 2023


IDXX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) 8.29 % - - -
Seq. Operating Income Change (Q4 MRQ) -10.89 % 5.41 % - -
Y / Y Operating Income Growth (Q4 TTM) 22.07 % 62.59 % -34.89 % -3.35 %
Seq. Operating Income Growth (Q4 TTM) 1.74 % 49.91 % -13.99 % -0.61 %
Operating Income 5 Year Avg. Change 17.43 % 12.33 % -1.45 % 9.25 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) 12.96 % - -20.02 % 4.58 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) -8.34 % -8.73 % 91.03 % -14.24 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) 24.44 % 69.84 % -26.91 % -0.75 %
Seq. Income from Cont. Ops. Change (Q4 TTM) 2.71 % 53.8 % 13.98 % 1.6 %
Income from Cont. Ops. 5 Year Avg. Change 17.52 % 8.91 % -6.22 % 7.7 %

IDXX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) 12.96 % - -19.89 % 0.1 %
Q / Q Net Income Growth (Q4 MRQ) -8.34 % -8.73 % -42.95 % -21.21 %
Y / Y Net Income Change (Q4 TTM) 24.44 % 69.84 % -2.58 % 0.52 %
Seq. Net Income Change (Q4 TTM) 2.71 % 53.8 % 10.21 % 0.54 %
Net Income 5 Year Avg. Growth 17.52 % 8.91 % -0.67 % 7.91 %

IDXX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) 12.72 % - -20.02 % 4.58 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) -8.19 % -10.49 % 91.03 % -14.24 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) 25.31 % 50.3 % - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) 2.67 % 108.65 % - 0 %
EPS from Cont. Ops. 5 Year Avg. Growth 18.57 % 0.52 % -6.22 % 7.7 %



IDXX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) 11.69 % - -19.89 % 7.7 %
Q / Q EPS Net Growth (Q4 MRQ) -8.31 % -10.49 % -42.95 % -21.21 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - 43.57 % - 39476.7 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) 2.47 % 102.07 % - 0.03 %
EPS Net 5 Year Avg. Change 18.75 % 8.91 % -0.67 % 7.91 %



Idexx Laboratories Inc improved it's EPS by 11.69% from the same quarter a year ago, in the forth quarter 2023, and underperformed the 14.93% rise in the In Vitro & In Vivo Diagnostic Substances industry, but beating the -19.89% decline in the Healthcare sector. Comparing forth quarter income per share growth, both In Vitro & In Vivo Diagnostic Substances industry and Idexx Laboratories Inc outperformed 0.1% overall market increase.

the bottom-line fell by -8.31% from the third quarter. Average annual income per share growth for Idexx Laboratories Inc is 18.75%, while S & P 500's average yearly income per share increase is 7.91%, including only Businesses with the forth quarter 2023 earnings.

IDXX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) 44.07 % 15.05 % -11.94 % -8.5 %
Seq. Free Cash Flow Change (Q4 MRQ) -8.29 % -14.24 % -9.13 % -2.26 %
Y / Y Free Cash Flow Change (Q4 TTM) 66.95 % 21.27 % -10.11 % 1.67 %
Seq. Free Cash Flow Change (Q4 TTM) 9.21 % -11.3 % -1.69 % 3.15 %
Free Cash Flow 5 Year Avg. Change 22.77 % 13.39 % 9.16 % 11.13 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) 814.26 % 15.11 % - -
Seq. Net Cash Flow Change (Q4 MRQ) -38.53 % -14.04 % - -
Y / Y Net Cash Flow Change (Q4 TTM) - 265.89 % - -
Seq. Net Cash Flow Change (Q4 TTM) - 5.71 % -43.2 % -
Net Cash Flow 5 Year Avg. Change - - 9.73 % -31 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) -33.87 % -81.06 % -4.13 % -16.49 %
Seq. Capital Expenditures Change (Q4 MRQ) -4.51 % -10.62 % 11.12 % -0.59 %
Y / Y Capital Expenditures Change (Q4 TTM) -15.87 % -31.33 % 7.65 % 19.55 %
Seq. Capital Expenditures Change (Q4 TTM) -11.09 % -39.24 % 2.6 % 26.04 %
Capital Expenditures 5 Year Avg. Change 1.68 % 16.29 % 8.01 % 8.33 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com